10 Apr 2015  |  Global
Drug Discovery Technology Alert. Novel Drug to Treat Bile Acid Synthesis Disorders; Drug for Treatment of Thyroid Cancer Receives FDA Approval; Drug Screening Technology Platform Based on Modulation of Integrin Activity
This issue profiles a novel drug to treat bile acid synthesis disorders, FDA approval for a drug for treatment of thyroid cancer, and a drug screening technology platform based on modulation of integrin activity.
13 Mar 2015  |  Global
Drug Discovery Technology Alert. Understanding Genes and Pathways to Optimize Drug Development; Intralumenal Device for Transmucosal Drug Delivery; Next Generation Protein-Based Medicines to Treat Immunological Disorders
This issue profiles understanding genes and pathways to optimize drug development, an intralumenal device for transmucosal drug delivery , and next generation protein-based medicines to treat immunological disorders.
13 Feb 2015  |  Global
Drug Discovery Technology Alert. Novel Vaccine Treatment for Meningococcal Disease Obtains FDA Clearance; Nasal Testosterone Replacement Therapy to Treat Male Hypogonadism; Injection Therapy to Control Hypocalcemia in Patients with Hypoparathyroidism
This issue profiles a vaccine treatment for meningococcal disease that obtains FDA clearance, a nasal testosterone replacement therapy to treat male hypogonadism, and an injection therapy to control hypocalcemia in patients with hypoparathyroidism.
23 Jan 2015  |  Global
Western Blotting Technology for the Present Day, High-Resolution Protein Image Database, Protein Folding Crucial for Alzheimer’s and Huntington’s Drug Discovery - Genetic Technology
This issue profiles western blotting technology for the present day, a high-resolution protein image database, and a study that explains the cruciality of protein folding for Alzheimer’s and Huntington’s drug discovery.
USD 187.50 save 25 %
09 Jan 2015  |  Global
Drug Discovery Technology Alert. Utilizing Platelet-Rich Plasma as a Nuclear Cell Differentiation Technology Platform; Increasing Reprogramming Efficiency of Induced Pluripotent Stem Cells
This issue profiles utilizing platelet-rich plasma as a nuclear cell differentiation technology platform, increasing reprogramming efficiency of induced pluripotent stem cells, and a drug for autoimmune uveitis that receives orphan drug designation in Europe.
13 Jun 2014  |  North America
Increasing Applications of Biomarkers are Driving Growth
This research service focuses on antiviral therapeutics for the treatment of the hepatitis C virus (HCV). A global product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HCV. Segmentation by drug class is provided, along with supporting information such as clinical trial t...
22 Sep 2010  |  Asia Pacific
This Market Engineering research service has been developed to address the dynamics of Drug Discovery in China. The market covers four main area, that is gene sequencing, target ID, target validation and lead discovery. This research service presents the key findings of drug discovery outsourcing in china. It provides insight and forecast of marke...
USD 5,212.50 save 25 %
05 Jun 2010  |  Global
This research service discusses the role of bioinformatics in drug discovery with a specific focus on in silico applications.
08 May 2009  |  Europe
This short issue based research provides a top level picture of the applications of in-silico tools within the drug discovery market in Europe.
31 Mar 2009  |  North America
The CEO 360 Perspective presentation provides a holistic view of the 7 perspectives that affect C-level driven decisions, within the Drug Discovery Technologies markets. This includes the global, integrated industry, technology, economic, competitive, customer and best practices perspective. Each perspective provides insight into the current and f...